SlideShare uma empresa Scribd logo
1 de 27
Jackrel Consulting, Inc.
Patent Agent, Expert Witness
and Consulting Services for
companies and individual
inventors.
Unpredictable Art
Patenting Chemical, Biological and Emerging Technologies
Overview
• MPEP 2164.03 “Relationship of Predictability of the Art and the Enablement
Requirement”
• Predictable vs. Unpredictable Technologies
• Chemical and Biological Technologies
• Emerging Technologies
2
MPEP 2164
The Enablement Requirement
“The enablement requirement refers to the requirement of 35 U.S.C. 112(a) or pre-AIA 35
U.S.C. 112, first paragraph that the specification describe how to make and how to use the
invention. The invention that one skilled in the art must be enabled to make and use is that
defined by the claim(s) of the particular application or patent.”
“The test of enablement is whether one reasonably skilled in the art could make or use the
invention from the disclosures in the patent coupled with information known in the art
without undue experimentation." United States v. Telectronics, Inc., 857 F.2d 778, 785, 8
USPQ2d 1217, 1223 (Fed. Cir. 1988)
3
MPEP 2164.03
Relationship of Predictability of the Art and the Enablement Requirement
• “The amount of guidance or direction needed to enable the invention is inversely
related to the amount of knowledge in the state of the art as well as the
predictability in the art. In re Fisher, 427 F.2d 833, 839, 166 USPQ 18, 24 (CCPA
1970).”
• “The ‘predictability or lack thereof’ in the art refers to the ability of one skilled in
the art to extrapolate the disclosed or known results to the claimed invention.”
• “[I]n the field of chemistry generally, there may be times when the well-known unpredictability
of chemical reactions will alone be enough to create a reasonable doubt as to the accuracy of a
particular broad statement put forward as enabling support for a claim.” In re Marzocchi, 439
F.2d 220, 223-24, 169 USPQ 367, 369-70 (CCPA 1971)
• “The scope of the required enablement varies inversely with the degree of
predictability involved, but even in unpredictable arts, a disclosure of every
operable species is not required.”
4
Unpredictable Art &
Emerging Technologies
• Chemical & Biological
• All variations of a claimed species must be enabled in the specification
• E.g., for chemical species with substitutable groups – the specification must “teach how
to make and use” all of the claimed species
• Emerging Technologies
• “New fields” (even if “predictable”) need more description to satisfy disclosure
obligations than more mature fields
• E.g., broad claims that cover different embodiments need to enable all of the variations
with sufficient description (without undue experimentation)
5
Predictable vs. Unpredictable
6
• In 1916 Einstein published his theory of
general relativity, stating that mass curves
space-time
• May 29, 1919, English scientists – led by
Sir Arthur Eddington – traveled to the
island of Príncipe off the west coast of
Africa to observe a total solar eclipse, and
confirmed that light from stars was bent
by the gravity of the sun
https://earthsky.org/human-world/may-29-
1919-solar-eclipse-einstein-relativity/
Predictable vs. Unpredictable
7
• In 1916, Einstein predicted the
existence of gravitational waves in
1916 in his general theory of relativity
• In 2016, LIGO, the Laser
Interferometer Gravitational Wave
Observatory, confirmed the first
observation of gravitational waves
https://www.ligo.caltech.edu/
Predictable vs. Unpredictable
8
• Organic molecules with biological
effects, such as psychoactive
effects or for treating ulcers
• In 1916, Einstein predicted the
existence of gravitational waves in
1916 in his general theory of relativity
• In 2016, LIGO, the Laser
Interferometer Gravitational Wave
Observatory, confirmed the first
observation of gravitational waves
https://www.ligo.caltech.edu/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
Chemical and Biological
• It can be difficult for a skilled person to predict which function or activity a
chemical or biological substance may possess
• Advantage: a newly found substance (and its use) is more likely to be deemed “not
obvious” to the skilled person, and hence, meet the statutory requirement of inventive
step (§ 103)
• Burden: when claiming a group of compounds, “providing one synthetic route and the
activity data of one compound may not be sufficient to support the assumption that all
claimed permutations of this compound can be synthesized and are active”
9
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
Chemical and Biological
• A generic structural formula does not necessarily inherently disclose the specific
compounds falling under the formula (otherwise no future chemistry inventions would be
possible since all conceivable new compounds fall under one known generic formula or
another).
10
Generic formula 1, Olanzapin (2), and Flumezapin (3)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
https://media.bardehle.com/contentdocuments/broschures/IP_R
eport_2009_I.pdf
Chemical and Biological
• German Federal Supreme
Court case (2008)
• “generic” 4′-(N-
methylpiperazinyl)-10H-
thieno[2,3-
b][1,5]benzodiazepine (1)
with the unspecified
residues R1 and R2
• General formula 1 does
not disclose 2
• Is compound 2 rendered
obvious by compound 3?
11
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
https://media.bardehle.com/contentdocuments/broschures/IP_R
eport_2009_I.pdf
German Federal Patent Court originally revoked Eli Lilly’s patent on
Olanzapin on the basis of lack of novelty, but that decision was reversed
in a ground-breaking decision of the Federal Supreme Court in 2008.
Generic formula 1, Olanzapin (2), and Flumezapin (3)
Chemical and Biological
• Is compound 2 rendered
obvious by compound 3?
• Activity data in the prior art
 a POSITA would
reasonably expect the
fluorine to enhance the
antipsychotic potency of the
compound
• Also, prior art had no
individualized compound
under the generic formula 1
that was not halogenated
•  POSITA had no reason or
incentive to modify
Flumezapin to compound 2
with no halogen
12
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
https://media.bardehle.com/contentdocuments/broschures/IP_R
eport_2009_I.pdf
In this decision, the Federal Supreme Court stated that it will change
course, and that a general formula does not disclose the individual
compounds falling in its scope.
Generic formula 1, Olanzapin (2), and Flumezapin (3)
KSR
US Supreme Court, 2007
• there needs to be no explicit motivation in the prior art to modify a given teaching
to arrive at the claimed subject-matter
• when there is a need to solve a problem and there is a finite number of identified,
predictable solutions, a person of ordinary skill has good reason to pursue the
known options within his or her technical grasp
• if this leads to the claimed solution, the same is likely an obvious product of ordinary skill and
not the product of innovation
• underlying KSR is technology from predicable art (a mechanism for combining an
electronic sensor with an adjustable automobile pedal)
• All elements as such and their function were known from the art, and the result of the
combination was predictable and hence obvious.
13
KSR and Unpredictable Arts
• US Court of Appeal for the Federal
Circuit (CAFC) – there still needs to be
some reason (motivation) to modify a
starting compound in order to arrive at
the claimed compound.
• E.g., Lansoprazole (known from the
art) is structurally similar Rabeprazole
(claimed compound).
• However, the CAFC did not find any
motivation in the art to substitute the
active groups.
• The court stated: “The record shows no
discernible reason for a skilled artisan to
begin with Lansoprazole only to drop
the very feature, the fluorinated
substituent, that gave this
advantageous property [lipophilicity].”
14
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
Lansoprazole (known) Rabeprazole (claimed)
United States Court of Appeal for the Federal Circuit.
EISAI v. DR. REDDY’S LABORATORY and TEVA
PHARMACEUTICALS No. 07–1397 (Fed. Cir. July 21, 2008)
Unpredictable Arts
Detailed Description – Supporting Examples
• Chemical and Biological patents have to show that a class of compounds is
supported by a set of examples
• enabled over the whole claimed range
• in full possession of the invention on the filing date (e.g., actual or constructive
reduction to practice)
• the activity underlying the claimed compounds is also present over the whole range
claimed
15
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
Unpredictable Arts
Detailed Description – Supporting Examples
• AbbVie v. Janssen Biotech, CAFC (2014)
• invalidated a claim for a class of antibodies with no structural definition (only defined
functionally in terms of a certain disassociation constant to a binding site)
• “the claimed scope reaches beyond what the inventors have contributed to the art,” (since the
inventors did not provide structural examples of antibodies that fulfill the claimed function)
• Wyeth v. Abbott Laboratories CAFC (2013)
• invalidated a broad genus claim directed at Rapamycin and its derivatives
• the disclosure only supported one single compound within the scope of the claims (Sirolimus)
• the skilled person would have to synthesize and biologically evaluate thousands of compounds to see if
they have the claimed properties
16
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
Unpredictable Arts – What to do
17
Cover as much
breadth as possible
with examples and
data (synthesis and
activity)
Provide guidance in
the description how to
extrapolate from
these examples/data
to the remaining scope
Emerging Technologies
• How much does a patent specification rely on the knowledge of a person of
ordinary skill in the art (POSITA) to provide support for certain claimed
embodiments?
• Can be tension between a company’s desire to protect valuable trade secrets
versus the need to provide an enabling disclosure
18
Emerging Technologies & Enablement
• Historically, predictable arts can be enabled by a single example
• Spectra-Physics, Inc. v. Coherent, Inc. (Fed. Cir. 1987)
• “New fields,” however, even if “predictable,” may not rely on knowledge of a
POSITA to satisfy disclosure obligations to the same extent to which inventions in
more mature fields may
• Automotive Technologies International v. BMW of North America (CAFC 2006)
• New guidance – can a POSITA make and use the entire claimed scope “without
undue experimentation”
• Trustees of Boston University v. Everlight Electronics Co., Ltd. (CAFC 2018)
• Guidelines on Examining Computer-Implemented Functional Claim Limitations for Compliance
with 35 U.S.C. 112 (USPTO, Jan 2019)
19
https://www.womblebonddickinson.com/us/insights/articles-and-
briefings/patenting-emerging-technologies-determining-how-far-
artisans-knowledge-goes
Emerging Technologies
Automotive Technologies International v. BMW of North America, CAFC ‘06
• The CAFC found all claims invalid due to lack of enablement
• Crash sensing devices used to determine when air bags were deployed
• The specification of the patent (US 5,231,253) described an embodiment
of the device utilizing a mechanical sensor in considerable detail
• It also described utilizing an electronic sensor, but included less detail
and relied on the POSITA’s knowledge.
• At trial, Automotive Tech’s expert testified that POSITA could use off-the-
shelf components and well-known circuit design and programming
 When the patent application was filed in 1992, air bag deployment
sensors were arguably still an emerging technology.
20
https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting-
emerging-technologies-determining-how-far-artisans-knowledge-goes
https://cafc.uscourts.gov/sites/default/files/opinions-orders/06-1013.pdf
Emerging Technologies
Automotive Technologies International v. BMW of North America, CAFC ‘06
1. A side impact crash sensor for a vehicle having front and rear
wheels, said sensor comprising:
(a) a housing;
(b) a mass within said housing movable relative to said
housing in response to accelerations of said housing;
(c) means responsive to the motion of said mass upon
acceleration of said housing in excess of a predetermined
threshold value, for initiating an occupant protection
apparatus; and
(d) means for mounting said housing onto at least one of a
side door of the vehicle and a side of the vehicle between the
centers of the front and rear wheels, in such a position and a
direction as to sense an impact into the side of said vehicle.
21
https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting-
emerging-technologies-determining-how-far-artisans-knowledge-goes
https://cafc.uscourts.gov/sites/default/files/opinions-orders/06-1013.pdf
Emerging Technologies
Sitrick vs Dreamworks, CAFC ‘08
• The CAFC found all claims invalid due to lack of enablement
• Integrating a user's audio signal or visual image into a pre-existing
video game or movie
• Defendants' two experts explained that a POSITA would not to be able
to take the teachings regarding video games and apply them to movies
 “The district court…in a detailed and thorough opinion granted
summary judgment in favor of Defendants because it found all asserted
claims of the '864 and '825 patents invalid for lack of enablement as to
movies. Sitrick v. Dreamworks, LLC, No. 03-4265 (N.D.Cal. July 21, 2006).
The district court did not reach the issue of whether the asserted claims
would have been enabled for video games. Id. at 73.”
22
https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting-
emerging-technologies-determining-how-far-artisans-knowledge-goes
https://www.courtlistener.com/opinion/210102/sitrick-v-dreamworks-llc/
FIG. 1A illustrates an embodiment of a user image
adapter interface system used in conjunction with
a video game apparatus, a user image storage
card, and a video game software or firmware card,
in accordance with the present invention
Emerging Technologies
Sitrick vs Dreamworks, CAFC ‘08
54. A method of integrating a user voice image into a presentation
output, the method comprising the steps of:
sampling a user's voice;
analyzing the sampled user's voice to provide user voice parameter
data representative of the user voice image;
storing the user voice parameter data;
synthesizing and interjecting the user's voice into the presentation
output responsive to the user voice parameter data comprising the
step of associating a particular predefined character image within
the presentation with the user's voice so that when the particular
predefined character is speaking, the user voice parameter data is
input as a model to a voice synthesizer that effects the integration of
the user's voice into the presentation output as associated with the
predefined character image.
23
https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting-
emerging-technologies-determining-how-far-artisans-knowledge-goes
https://www.courtlistener.com/opinion/210102/sitrick-v-dreamworks-llc/
FIG. 1A illustrates an embodiment of a user image
adapter interface system used in conjunction with
a video game apparatus, a user image storage
card, and a video game software or firmware card,
in accordance with the present invention
Unpredictable Arts & Emerging
Technologies – What to do
24
Cover as much
breadth as possible
with examples and
data (synthesis and
activity)
Provide guidance in
the description how to
extrapolate from
these examples/data
to the remaining scope
Unpredictable Arts & Emerging
Technologies – What to do
25
Comprehensively
describe the
technology, even
those made from
components that
are “off-the-shelf”
Carefully consider
the scope of the
claim terms being
construed
Consider not filing
patents in certain
areas to avoid
disclosing trade
secrets
Jackrel Consulting, Inc.
Patent Agent, Expert Witness
and Consulting Services for
companies and individual
inventors.
Thank You
26
Emerging Technologies
• “By classifying the field of Automotive Tech’s invention as a “new field”—despite using off-the-shelf components and well-known design
techniques—the Federal Circuit appears to have eviscerated its predictable arts doctrine from Spectra-Physics, Inc., leaving a significant question
of where the practitioner should draw the line on the amount of disclosure required in a patent specification for an invention in a new field versus
a predictable art.”
• “For entities more concerned with trade secret protection, it is important for the practitioner to keep in mind that questions of patent invention
enablement under 35 U.S.C. Section 112(a) are evaluated against “claimed” subject matter, with a focus on whether everythingwithin the scope
of each claim is enabled. If information to enable such claims cannot be easily reverse engineered and therefore has more value as a trade secret,
the practitioner, in close partnership with the inventor or other subject matter experts, should consider omitting claims which might require
disclosure of non-readily discernable information that would otherwise need to be disclosed in order to satisfy patent enablement standards.”
• “Finally, the lack of clarity on the extent to which a specification may rely on the artisan’s knowledge has important downstream effects on
strategies taken by patentees looking to assert patents. With contradictory and unclear guidance on when and to what degree apatent disclosure
may rely on the artisan’s knowledge to fill gaps in an otherwise non-enabling disclosure, patentees should carefully consider the scope of claim
terms being construed through the lens of a careful and thorough analysis of not only the level of detail in a patent’s specification, but also the
state of the art of the field of that invention at the time that the underlying patent application was first filed. “
• “For that reason, if, years after a patent application was originally filed, a patentee or its subject matter experts believes that there is a credible
risk that the field of the patented invention may be determined to be “new” at the time of the underlying patent application’s filing, the patentee
would benefit by either narrowing its claim term constructions and even not asserting claims that are found to have a less robust enabling
disclosure, in order to avoid an enablement challenge that ultimately invalidates the entire patent, as was the case in the Fed Circuit’s 2008
decision in Sitrick v. Dreamworks, LLC. “
27
https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting-
emerging-technologies-determining-how-far-artisans-knowledge-goes

Mais conteúdo relacionado

Semelhante a Predictable Results from Unpredictable Arts

PTO’s 2010 Obviousness Guidelines: Pharmaceuticals & Biotechnology
PTO’s 2010 Obviousness Guidelines:  Pharmaceuticals & BiotechnologyPTO’s 2010 Obviousness Guidelines:  Pharmaceuticals & Biotechnology
PTO’s 2010 Obviousness Guidelines: Pharmaceuticals & Biotechnologykblaurence
 
Biotechnology Novelty And Nonobviousness 14 Sep10
Biotechnology Novelty And Nonobviousness 14 Sep10Biotechnology Novelty And Nonobviousness 14 Sep10
Biotechnology Novelty And Nonobviousness 14 Sep10Gary M. Myles, Ph.D.
 
Doctrine of equivalents
Doctrine of equivalentsDoctrine of equivalents
Doctrine of equivalentsraokavi
 
Significant U.S. cases in 2010
Significant U.S. cases in 2010Significant U.S. cases in 2010
Significant U.S. cases in 2010briandorn
 
Ariad and Written Description
Ariad and Written DescriptionAriad and Written Description
Ariad and Written Descriptionpmrivard
 
Presentation_Costa Rica 2014
Presentation_Costa Rica 2014Presentation_Costa Rica 2014
Presentation_Costa Rica 2014Daniel Santos
 
European and US Patent Law
European and US Patent LawEuropean and US Patent Law
European and US Patent LawIP Dome
 
Best Practices: IP Strategies for Diagnostics
Best Practices: IP Strategies for DiagnosticsBest Practices: IP Strategies for Diagnostics
Best Practices: IP Strategies for DiagnosticsMaRS Discovery District
 
Biotech patents after_prometheus_les
Biotech patents after_prometheus_lesBiotech patents after_prometheus_les
Biotech patents after_prometheus_lesdbania
 
Biotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After BilskiBiotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After Bilskiwardjohn1346
 
11 Biotechnology Patents_Subject Matter Exclusions.pptx
11 Biotechnology Patents_Subject Matter Exclusions.pptx11 Biotechnology Patents_Subject Matter Exclusions.pptx
11 Biotechnology Patents_Subject Matter Exclusions.pptxssuserdf29f0
 
SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal ...
SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal ...SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal ...
SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal ...SterneKessler
 
Patenting Biotech inventions in India
Patenting Biotech inventions in IndiaPatenting Biotech inventions in India
Patenting Biotech inventions in IndiaPankaj Kumar
 
Patents on Software and Business Methods: Have the Rules Changed?
Patents on Software and Business Methods: Have the Rules Changed?Patents on Software and Business Methods: Have the Rules Changed?
Patents on Software and Business Methods: Have the Rules Changed?Karl Larson
 
4 21 15 FINAL Slides
4 21 15 FINAL Slides4 21 15 FINAL Slides
4 21 15 FINAL SlidesRoy Issac
 

Semelhante a Predictable Results from Unpredictable Arts (20)

PTO’s 2010 Obviousness Guidelines: Pharmaceuticals & Biotechnology
PTO’s 2010 Obviousness Guidelines:  Pharmaceuticals & BiotechnologyPTO’s 2010 Obviousness Guidelines:  Pharmaceuticals & Biotechnology
PTO’s 2010 Obviousness Guidelines: Pharmaceuticals & Biotechnology
 
2017 02-15 uwls-apl_biotech 101
2017 02-15 uwls-apl_biotech 1012017 02-15 uwls-apl_biotech 101
2017 02-15 uwls-apl_biotech 101
 
Biotechnology Novelty And Nonobviousness 14 Sep10
Biotechnology Novelty And Nonobviousness 14 Sep10Biotechnology Novelty And Nonobviousness 14 Sep10
Biotechnology Novelty And Nonobviousness 14 Sep10
 
Doctrine of equivalents
Doctrine of equivalentsDoctrine of equivalents
Doctrine of equivalents
 
Significant U.S. cases in 2010
Significant U.S. cases in 2010Significant U.S. cases in 2010
Significant U.S. cases in 2010
 
Post-KSR Obviousness
Post-KSR ObviousnessPost-KSR Obviousness
Post-KSR Obviousness
 
Ariad and Written Description
Ariad and Written DescriptionAriad and Written Description
Ariad and Written Description
 
Presentation_Costa Rica 2014
Presentation_Costa Rica 2014Presentation_Costa Rica 2014
Presentation_Costa Rica 2014
 
European and US Patent Law
European and US Patent LawEuropean and US Patent Law
European and US Patent Law
 
Biotechnology Patent Eligibility
Biotechnology Patent EligibilityBiotechnology Patent Eligibility
Biotechnology Patent Eligibility
 
Best Practices: IP Strategies for Diagnostics
Best Practices: IP Strategies for DiagnosticsBest Practices: IP Strategies for Diagnostics
Best Practices: IP Strategies for Diagnostics
 
Knobbe Martens and Forresters Seminar
Knobbe Martens and Forresters SeminarKnobbe Martens and Forresters Seminar
Knobbe Martens and Forresters Seminar
 
Biotech patents after_prometheus_les
Biotech patents after_prometheus_lesBiotech patents after_prometheus_les
Biotech patents after_prometheus_les
 
Biotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After BilskiBiotech Patentable Subject Matter After Bilski
Biotech Patentable Subject Matter After Bilski
 
Knowledge is Property- All YOU need to know ABC of Patent Searching
Knowledge is Property- All YOU need to know ABC of Patent SearchingKnowledge is Property- All YOU need to know ABC of Patent Searching
Knowledge is Property- All YOU need to know ABC of Patent Searching
 
11 Biotechnology Patents_Subject Matter Exclusions.pptx
11 Biotechnology Patents_Subject Matter Exclusions.pptx11 Biotechnology Patents_Subject Matter Exclusions.pptx
11 Biotechnology Patents_Subject Matter Exclusions.pptx
 
SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal ...
SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal ...SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal ...
SKGF_Presentation_Antibodies, Patents and Freedom to Operate: The Monoclonal ...
 
Patenting Biotech inventions in India
Patenting Biotech inventions in IndiaPatenting Biotech inventions in India
Patenting Biotech inventions in India
 
Patents on Software and Business Methods: Have the Rules Changed?
Patents on Software and Business Methods: Have the Rules Changed?Patents on Software and Business Methods: Have the Rules Changed?
Patents on Software and Business Methods: Have the Rules Changed?
 
4 21 15 FINAL Slides
4 21 15 FINAL Slides4 21 15 FINAL Slides
4 21 15 FINAL Slides
 

Mais de Aurora Consulting

CAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction FailsCAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction FailsAurora Consulting
 
Patents and AI: Current Tools, Future Solutions
Patents and AI: Current Tools, Future SolutionsPatents and AI: Current Tools, Future Solutions
Patents and AI: Current Tools, Future SolutionsAurora Consulting
 
Claim Construction: Building Strong Patent Foundations
Claim Construction: Building Strong Patent FoundationsClaim Construction: Building Strong Patent Foundations
Claim Construction: Building Strong Patent FoundationsAurora Consulting
 
Protect Before You Pitch (MichBio)
Protect Before You Pitch (MichBio)Protect Before You Pitch (MichBio)
Protect Before You Pitch (MichBio)Aurora Consulting
 
Government Grants and Patent Rights
Government Grants and Patent RightsGovernment Grants and Patent Rights
Government Grants and Patent RightsAurora Consulting
 
Open Source and Patent Rights: Collaboration with Consequences
Open Source and Patent Rights: Collaboration with ConsequencesOpen Source and Patent Rights: Collaboration with Consequences
Open Source and Patent Rights: Collaboration with ConsequencesAurora Consulting
 
Into the Patentverse Vol. 2: AR, VR, and Virtual Infringement
Into the Patentverse Vol. 2: AR, VR, and Virtual InfringementInto the Patentverse Vol. 2: AR, VR, and Virtual Infringement
Into the Patentverse Vol. 2: AR, VR, and Virtual InfringementAurora Consulting
 
Mean Plus Function: : The Risk of Losing Your Way
Mean Plus Function: : The Risk of Losing Your WayMean Plus Function: : The Risk of Losing Your Way
Mean Plus Function: : The Risk of Losing Your WayAurora Consulting
 
American Axle: 101 Rejections of Mechanical Claims
American Axle: 101 Rejections of Mechanical ClaimsAmerican Axle: 101 Rejections of Mechanical Claims
American Axle: 101 Rejections of Mechanical ClaimsAurora Consulting
 
Prenuptial Patenting: Responsible Engagement with Engineering Firms
Prenuptial Patenting: Responsible Engagement with Engineering FirmsPrenuptial Patenting: Responsible Engagement with Engineering Firms
Prenuptial Patenting: Responsible Engagement with Engineering FirmsAurora Consulting
 
Fortifying Life Science Patents: Eligibility and Enablement
Fortifying Life Science Patents: Eligibility and EnablementFortifying Life Science Patents: Eligibility and Enablement
Fortifying Life Science Patents: Eligibility and EnablementAurora Consulting
 
Web 3 and IP: Cryptocurrencies, Blockchain, and NFTs
Web 3 and IP: Cryptocurrencies, Blockchain, and NFTsWeb 3 and IP: Cryptocurrencies, Blockchain, and NFTs
Web 3 and IP: Cryptocurrencies, Blockchain, and NFTsAurora Consulting
 
Inventorship: Who should be listed as an inventor for a patent?
Inventorship: Who should be listed as an inventor for a patent?Inventorship: Who should be listed as an inventor for a patent?
Inventorship: Who should be listed as an inventor for a patent?Aurora Consulting
 
Decrypting Software Patents: Key Insights for IP Success
Decrypting Software Patents: Key Insights for IP SuccessDecrypting Software Patents: Key Insights for IP Success
Decrypting Software Patents: Key Insights for IP SuccessAurora Consulting
 
Patent Searching: Sleuthing Your Way to Stronger Patents
Patent Searching: Sleuthing Your Way to Stronger PatentsPatent Searching: Sleuthing Your Way to Stronger Patents
Patent Searching: Sleuthing Your Way to Stronger PatentsAurora Consulting
 

Mais de Aurora Consulting (20)

CAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction FailsCAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction Fails
 
Patents and AI: Current Tools, Future Solutions
Patents and AI: Current Tools, Future SolutionsPatents and AI: Current Tools, Future Solutions
Patents and AI: Current Tools, Future Solutions
 
Claim Construction: Building Strong Patent Foundations
Claim Construction: Building Strong Patent FoundationsClaim Construction: Building Strong Patent Foundations
Claim Construction: Building Strong Patent Foundations
 
Patenting Games.pdf
Patenting Games.pdfPatenting Games.pdf
Patenting Games.pdf
 
Patent Claims
Patent ClaimsPatent Claims
Patent Claims
 
Protect Before You Pitch (MichBio)
Protect Before You Pitch (MichBio)Protect Before You Pitch (MichBio)
Protect Before You Pitch (MichBio)
 
Government Grants and Patent Rights
Government Grants and Patent RightsGovernment Grants and Patent Rights
Government Grants and Patent Rights
 
Open Source and Patent Rights: Collaboration with Consequences
Open Source and Patent Rights: Collaboration with ConsequencesOpen Source and Patent Rights: Collaboration with Consequences
Open Source and Patent Rights: Collaboration with Consequences
 
Foreign Filing Licenses
Foreign Filing LicensesForeign Filing Licenses
Foreign Filing Licenses
 
Top 3 Inventor Mistakes
Top 3 Inventor MistakesTop 3 Inventor Mistakes
Top 3 Inventor Mistakes
 
Into the Patentverse Vol. 2: AR, VR, and Virtual Infringement
Into the Patentverse Vol. 2: AR, VR, and Virtual InfringementInto the Patentverse Vol. 2: AR, VR, and Virtual Infringement
Into the Patentverse Vol. 2: AR, VR, and Virtual Infringement
 
Mean Plus Function: : The Risk of Losing Your Way
Mean Plus Function: : The Risk of Losing Your WayMean Plus Function: : The Risk of Losing Your Way
Mean Plus Function: : The Risk of Losing Your Way
 
American Axle: 101 Rejections of Mechanical Claims
American Axle: 101 Rejections of Mechanical ClaimsAmerican Axle: 101 Rejections of Mechanical Claims
American Axle: 101 Rejections of Mechanical Claims
 
Prenuptial Patenting: Responsible Engagement with Engineering Firms
Prenuptial Patenting: Responsible Engagement with Engineering FirmsPrenuptial Patenting: Responsible Engagement with Engineering Firms
Prenuptial Patenting: Responsible Engagement with Engineering Firms
 
Fortifying Life Science Patents: Eligibility and Enablement
Fortifying Life Science Patents: Eligibility and EnablementFortifying Life Science Patents: Eligibility and Enablement
Fortifying Life Science Patents: Eligibility and Enablement
 
Web 3 and IP: Cryptocurrencies, Blockchain, and NFTs
Web 3 and IP: Cryptocurrencies, Blockchain, and NFTsWeb 3 and IP: Cryptocurrencies, Blockchain, and NFTs
Web 3 and IP: Cryptocurrencies, Blockchain, and NFTs
 
Common Ownership
Common OwnershipCommon Ownership
Common Ownership
 
Inventorship: Who should be listed as an inventor for a patent?
Inventorship: Who should be listed as an inventor for a patent?Inventorship: Who should be listed as an inventor for a patent?
Inventorship: Who should be listed as an inventor for a patent?
 
Decrypting Software Patents: Key Insights for IP Success
Decrypting Software Patents: Key Insights for IP SuccessDecrypting Software Patents: Key Insights for IP Success
Decrypting Software Patents: Key Insights for IP Success
 
Patent Searching: Sleuthing Your Way to Stronger Patents
Patent Searching: Sleuthing Your Way to Stronger PatentsPatent Searching: Sleuthing Your Way to Stronger Patents
Patent Searching: Sleuthing Your Way to Stronger Patents
 

Último

How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerThousandEyes
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusZilliz
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...apidays
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MIND CTI
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Victor Rentea
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamUiPathCommunity
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native ApplicationsWSO2
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAndrey Devyatkin
 
WSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...Zilliz
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityWSO2
 
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelMcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelDeepika Singh
 
Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Zilliz
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingEdi Saputra
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfOrbitshub
 

Último (20)

How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
WSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering Developers
 
Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital Adaptability
 
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelMcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
 

Predictable Results from Unpredictable Arts

  • 1. Jackrel Consulting, Inc. Patent Agent, Expert Witness and Consulting Services for companies and individual inventors. Unpredictable Art Patenting Chemical, Biological and Emerging Technologies
  • 2. Overview • MPEP 2164.03 “Relationship of Predictability of the Art and the Enablement Requirement” • Predictable vs. Unpredictable Technologies • Chemical and Biological Technologies • Emerging Technologies 2
  • 3. MPEP 2164 The Enablement Requirement “The enablement requirement refers to the requirement of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph that the specification describe how to make and how to use the invention. The invention that one skilled in the art must be enabled to make and use is that defined by the claim(s) of the particular application or patent.” “The test of enablement is whether one reasonably skilled in the art could make or use the invention from the disclosures in the patent coupled with information known in the art without undue experimentation." United States v. Telectronics, Inc., 857 F.2d 778, 785, 8 USPQ2d 1217, 1223 (Fed. Cir. 1988) 3
  • 4. MPEP 2164.03 Relationship of Predictability of the Art and the Enablement Requirement • “The amount of guidance or direction needed to enable the invention is inversely related to the amount of knowledge in the state of the art as well as the predictability in the art. In re Fisher, 427 F.2d 833, 839, 166 USPQ 18, 24 (CCPA 1970).” • “The ‘predictability or lack thereof’ in the art refers to the ability of one skilled in the art to extrapolate the disclosed or known results to the claimed invention.” • “[I]n the field of chemistry generally, there may be times when the well-known unpredictability of chemical reactions will alone be enough to create a reasonable doubt as to the accuracy of a particular broad statement put forward as enabling support for a claim.” In re Marzocchi, 439 F.2d 220, 223-24, 169 USPQ 367, 369-70 (CCPA 1971) • “The scope of the required enablement varies inversely with the degree of predictability involved, but even in unpredictable arts, a disclosure of every operable species is not required.” 4
  • 5. Unpredictable Art & Emerging Technologies • Chemical & Biological • All variations of a claimed species must be enabled in the specification • E.g., for chemical species with substitutable groups – the specification must “teach how to make and use” all of the claimed species • Emerging Technologies • “New fields” (even if “predictable”) need more description to satisfy disclosure obligations than more mature fields • E.g., broad claims that cover different embodiments need to enable all of the variations with sufficient description (without undue experimentation) 5
  • 6. Predictable vs. Unpredictable 6 • In 1916 Einstein published his theory of general relativity, stating that mass curves space-time • May 29, 1919, English scientists – led by Sir Arthur Eddington – traveled to the island of Príncipe off the west coast of Africa to observe a total solar eclipse, and confirmed that light from stars was bent by the gravity of the sun https://earthsky.org/human-world/may-29- 1919-solar-eclipse-einstein-relativity/
  • 7. Predictable vs. Unpredictable 7 • In 1916, Einstein predicted the existence of gravitational waves in 1916 in his general theory of relativity • In 2016, LIGO, the Laser Interferometer Gravitational Wave Observatory, confirmed the first observation of gravitational waves https://www.ligo.caltech.edu/
  • 8. Predictable vs. Unpredictable 8 • Organic molecules with biological effects, such as psychoactive effects or for treating ulcers • In 1916, Einstein predicted the existence of gravitational waves in 1916 in his general theory of relativity • In 2016, LIGO, the Laser Interferometer Gravitational Wave Observatory, confirmed the first observation of gravitational waves https://www.ligo.caltech.edu/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
  • 9. Chemical and Biological • It can be difficult for a skilled person to predict which function or activity a chemical or biological substance may possess • Advantage: a newly found substance (and its use) is more likely to be deemed “not obvious” to the skilled person, and hence, meet the statutory requirement of inventive step (§ 103) • Burden: when claiming a group of compounds, “providing one synthetic route and the activity data of one compound may not be sufficient to support the assumption that all claimed permutations of this compound can be synthesized and are active” 9 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
  • 10. Chemical and Biological • A generic structural formula does not necessarily inherently disclose the specific compounds falling under the formula (otherwise no future chemistry inventions would be possible since all conceivable new compounds fall under one known generic formula or another). 10 Generic formula 1, Olanzapin (2), and Flumezapin (3) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/ https://media.bardehle.com/contentdocuments/broschures/IP_R eport_2009_I.pdf
  • 11. Chemical and Biological • German Federal Supreme Court case (2008) • “generic” 4′-(N- methylpiperazinyl)-10H- thieno[2,3- b][1,5]benzodiazepine (1) with the unspecified residues R1 and R2 • General formula 1 does not disclose 2 • Is compound 2 rendered obvious by compound 3? 11 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/ https://media.bardehle.com/contentdocuments/broschures/IP_R eport_2009_I.pdf German Federal Patent Court originally revoked Eli Lilly’s patent on Olanzapin on the basis of lack of novelty, but that decision was reversed in a ground-breaking decision of the Federal Supreme Court in 2008. Generic formula 1, Olanzapin (2), and Flumezapin (3)
  • 12. Chemical and Biological • Is compound 2 rendered obvious by compound 3? • Activity data in the prior art  a POSITA would reasonably expect the fluorine to enhance the antipsychotic potency of the compound • Also, prior art had no individualized compound under the generic formula 1 that was not halogenated •  POSITA had no reason or incentive to modify Flumezapin to compound 2 with no halogen 12 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/ https://media.bardehle.com/contentdocuments/broschures/IP_R eport_2009_I.pdf In this decision, the Federal Supreme Court stated that it will change course, and that a general formula does not disclose the individual compounds falling in its scope. Generic formula 1, Olanzapin (2), and Flumezapin (3)
  • 13. KSR US Supreme Court, 2007 • there needs to be no explicit motivation in the prior art to modify a given teaching to arrive at the claimed subject-matter • when there is a need to solve a problem and there is a finite number of identified, predictable solutions, a person of ordinary skill has good reason to pursue the known options within his or her technical grasp • if this leads to the claimed solution, the same is likely an obvious product of ordinary skill and not the product of innovation • underlying KSR is technology from predicable art (a mechanism for combining an electronic sensor with an adjustable automobile pedal) • All elements as such and their function were known from the art, and the result of the combination was predictable and hence obvious. 13
  • 14. KSR and Unpredictable Arts • US Court of Appeal for the Federal Circuit (CAFC) – there still needs to be some reason (motivation) to modify a starting compound in order to arrive at the claimed compound. • E.g., Lansoprazole (known from the art) is structurally similar Rabeprazole (claimed compound). • However, the CAFC did not find any motivation in the art to substitute the active groups. • The court stated: “The record shows no discernible reason for a skilled artisan to begin with Lansoprazole only to drop the very feature, the fluorinated substituent, that gave this advantageous property [lipophilicity].” 14 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/ Lansoprazole (known) Rabeprazole (claimed) United States Court of Appeal for the Federal Circuit. EISAI v. DR. REDDY’S LABORATORY and TEVA PHARMACEUTICALS No. 07–1397 (Fed. Cir. July 21, 2008)
  • 15. Unpredictable Arts Detailed Description – Supporting Examples • Chemical and Biological patents have to show that a class of compounds is supported by a set of examples • enabled over the whole claimed range • in full possession of the invention on the filing date (e.g., actual or constructive reduction to practice) • the activity underlying the claimed compounds is also present over the whole range claimed 15 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
  • 16. Unpredictable Arts Detailed Description – Supporting Examples • AbbVie v. Janssen Biotech, CAFC (2014) • invalidated a claim for a class of antibodies with no structural definition (only defined functionally in terms of a certain disassociation constant to a binding site) • “the claimed scope reaches beyond what the inventors have contributed to the art,” (since the inventors did not provide structural examples of antibodies that fulfill the claimed function) • Wyeth v. Abbott Laboratories CAFC (2013) • invalidated a broad genus claim directed at Rapamycin and its derivatives • the disclosure only supported one single compound within the scope of the claims (Sirolimus) • the skilled person would have to synthesize and biologically evaluate thousands of compounds to see if they have the claimed properties 16 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416422/
  • 17. Unpredictable Arts – What to do 17 Cover as much breadth as possible with examples and data (synthesis and activity) Provide guidance in the description how to extrapolate from these examples/data to the remaining scope
  • 18. Emerging Technologies • How much does a patent specification rely on the knowledge of a person of ordinary skill in the art (POSITA) to provide support for certain claimed embodiments? • Can be tension between a company’s desire to protect valuable trade secrets versus the need to provide an enabling disclosure 18
  • 19. Emerging Technologies & Enablement • Historically, predictable arts can be enabled by a single example • Spectra-Physics, Inc. v. Coherent, Inc. (Fed. Cir. 1987) • “New fields,” however, even if “predictable,” may not rely on knowledge of a POSITA to satisfy disclosure obligations to the same extent to which inventions in more mature fields may • Automotive Technologies International v. BMW of North America (CAFC 2006) • New guidance – can a POSITA make and use the entire claimed scope “without undue experimentation” • Trustees of Boston University v. Everlight Electronics Co., Ltd. (CAFC 2018) • Guidelines on Examining Computer-Implemented Functional Claim Limitations for Compliance with 35 U.S.C. 112 (USPTO, Jan 2019) 19 https://www.womblebonddickinson.com/us/insights/articles-and- briefings/patenting-emerging-technologies-determining-how-far- artisans-knowledge-goes
  • 20. Emerging Technologies Automotive Technologies International v. BMW of North America, CAFC ‘06 • The CAFC found all claims invalid due to lack of enablement • Crash sensing devices used to determine when air bags were deployed • The specification of the patent (US 5,231,253) described an embodiment of the device utilizing a mechanical sensor in considerable detail • It also described utilizing an electronic sensor, but included less detail and relied on the POSITA’s knowledge. • At trial, Automotive Tech’s expert testified that POSITA could use off-the- shelf components and well-known circuit design and programming  When the patent application was filed in 1992, air bag deployment sensors were arguably still an emerging technology. 20 https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting- emerging-technologies-determining-how-far-artisans-knowledge-goes https://cafc.uscourts.gov/sites/default/files/opinions-orders/06-1013.pdf
  • 21. Emerging Technologies Automotive Technologies International v. BMW of North America, CAFC ‘06 1. A side impact crash sensor for a vehicle having front and rear wheels, said sensor comprising: (a) a housing; (b) a mass within said housing movable relative to said housing in response to accelerations of said housing; (c) means responsive to the motion of said mass upon acceleration of said housing in excess of a predetermined threshold value, for initiating an occupant protection apparatus; and (d) means for mounting said housing onto at least one of a side door of the vehicle and a side of the vehicle between the centers of the front and rear wheels, in such a position and a direction as to sense an impact into the side of said vehicle. 21 https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting- emerging-technologies-determining-how-far-artisans-knowledge-goes https://cafc.uscourts.gov/sites/default/files/opinions-orders/06-1013.pdf
  • 22. Emerging Technologies Sitrick vs Dreamworks, CAFC ‘08 • The CAFC found all claims invalid due to lack of enablement • Integrating a user's audio signal or visual image into a pre-existing video game or movie • Defendants' two experts explained that a POSITA would not to be able to take the teachings regarding video games and apply them to movies  “The district court…in a detailed and thorough opinion granted summary judgment in favor of Defendants because it found all asserted claims of the '864 and '825 patents invalid for lack of enablement as to movies. Sitrick v. Dreamworks, LLC, No. 03-4265 (N.D.Cal. July 21, 2006). The district court did not reach the issue of whether the asserted claims would have been enabled for video games. Id. at 73.” 22 https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting- emerging-technologies-determining-how-far-artisans-knowledge-goes https://www.courtlistener.com/opinion/210102/sitrick-v-dreamworks-llc/ FIG. 1A illustrates an embodiment of a user image adapter interface system used in conjunction with a video game apparatus, a user image storage card, and a video game software or firmware card, in accordance with the present invention
  • 23. Emerging Technologies Sitrick vs Dreamworks, CAFC ‘08 54. A method of integrating a user voice image into a presentation output, the method comprising the steps of: sampling a user's voice; analyzing the sampled user's voice to provide user voice parameter data representative of the user voice image; storing the user voice parameter data; synthesizing and interjecting the user's voice into the presentation output responsive to the user voice parameter data comprising the step of associating a particular predefined character image within the presentation with the user's voice so that when the particular predefined character is speaking, the user voice parameter data is input as a model to a voice synthesizer that effects the integration of the user's voice into the presentation output as associated with the predefined character image. 23 https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting- emerging-technologies-determining-how-far-artisans-knowledge-goes https://www.courtlistener.com/opinion/210102/sitrick-v-dreamworks-llc/ FIG. 1A illustrates an embodiment of a user image adapter interface system used in conjunction with a video game apparatus, a user image storage card, and a video game software or firmware card, in accordance with the present invention
  • 24. Unpredictable Arts & Emerging Technologies – What to do 24 Cover as much breadth as possible with examples and data (synthesis and activity) Provide guidance in the description how to extrapolate from these examples/data to the remaining scope
  • 25. Unpredictable Arts & Emerging Technologies – What to do 25 Comprehensively describe the technology, even those made from components that are “off-the-shelf” Carefully consider the scope of the claim terms being construed Consider not filing patents in certain areas to avoid disclosing trade secrets
  • 26. Jackrel Consulting, Inc. Patent Agent, Expert Witness and Consulting Services for companies and individual inventors. Thank You 26
  • 27. Emerging Technologies • “By classifying the field of Automotive Tech’s invention as a “new field”—despite using off-the-shelf components and well-known design techniques—the Federal Circuit appears to have eviscerated its predictable arts doctrine from Spectra-Physics, Inc., leaving a significant question of where the practitioner should draw the line on the amount of disclosure required in a patent specification for an invention in a new field versus a predictable art.” • “For entities more concerned with trade secret protection, it is important for the practitioner to keep in mind that questions of patent invention enablement under 35 U.S.C. Section 112(a) are evaluated against “claimed” subject matter, with a focus on whether everythingwithin the scope of each claim is enabled. If information to enable such claims cannot be easily reverse engineered and therefore has more value as a trade secret, the practitioner, in close partnership with the inventor or other subject matter experts, should consider omitting claims which might require disclosure of non-readily discernable information that would otherwise need to be disclosed in order to satisfy patent enablement standards.” • “Finally, the lack of clarity on the extent to which a specification may rely on the artisan’s knowledge has important downstream effects on strategies taken by patentees looking to assert patents. With contradictory and unclear guidance on when and to what degree apatent disclosure may rely on the artisan’s knowledge to fill gaps in an otherwise non-enabling disclosure, patentees should carefully consider the scope of claim terms being construed through the lens of a careful and thorough analysis of not only the level of detail in a patent’s specification, but also the state of the art of the field of that invention at the time that the underlying patent application was first filed. “ • “For that reason, if, years after a patent application was originally filed, a patentee or its subject matter experts believes that there is a credible risk that the field of the patented invention may be determined to be “new” at the time of the underlying patent application’s filing, the patentee would benefit by either narrowing its claim term constructions and even not asserting claims that are found to have a less robust enabling disclosure, in order to avoid an enablement challenge that ultimately invalidates the entire patent, as was the case in the Fed Circuit’s 2008 decision in Sitrick v. Dreamworks, LLC. “ 27 https://www.womblebonddickinson.com/us/insights/articles-and-briefings/patenting- emerging-technologies-determining-how-far-artisans-knowledge-goes